Researchers identify new blood markers that may detect early pancreatic cancer
For Immediate Release
Friday, January 30, 2026
Contact:
NIH Office of Communications
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer. The new test could improve survival rates from pancreatic cancer, which tends to be diagnosed at late stages when therapy is less likely to be effective. The findings were published in Clinical Cancer Research.
Overall, only about 1 in 10 pancreatic cancer patients survive more than five years from diagnosis. However, experts expect that when ...